Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study
- Chien Yu Cheng
- , Ying Shih Su
- , Chyi Liang Chen
- , Mingi Chang
- , Shu Wei Huang
- , Peng Nien Huang
- , Shin Ru Shih
- , Yu Shen Hsu
- , Cheng Hsun Chiu*
*Corresponding author for this work
Research output: Contribution to journal › Journal Article › peer-review